Sars-CoV-2 Infections and Covid-19 Fatality
Estimation of Infection Fatality Ratio and Current Prevalence
Bibliographic Data
| ID | 15463563 |
|---|---|
| Authors | Marco Pota (0000-0001-6825-6393, Institute for High Performance Computing and Networking, corresponding author), Andrea Pota (UOC Nefrologia e Dialisi Ospedale del Mare, 80147 Napoli, Italy), Maria Luisa Sirico (UOC Nefrologia e Dialisi Ospedale del Mare, 80147 Napoli, Italy), Massimo Esposito (0000-0002-7196-7994, Institute for High Performance Computing and Networking) |
| Year | 2020 |
| Volume | 17 |
| Issue | 24 |
| Pages | 9290-9290 |
| Publication date | 2020-12-11 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Environmental Research and Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1661-7827 • E-ISSN: 1660-4601 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/ijerph17249290 |
| PMID | 33322572 |
| OpenAlex | W3111006708 |
| Language | EN |
| References cited | 31 |
COVID-19 is one of the most important problems for public health, according to the number of deaths associated to this pathology reported so far. However, from the epidemiological point of view, the dimension of the problem is still unknown, since the number of actual cases of SARS-CoV-2 infected people is underestimated, due to limited testing. This paper aims at estimating the actual Infection Fatality Ratio (number of deaths with respect to the number of infected people) and the actual current prevalence (number of infected people with respect to the entire population), both in a specific population and all over the world. With this aim, this paper proposes a method to estimate Infection Fatality Ratio of a still ongoing infection, based on a daily estimation, and on the relationship between this estimation and the number of tests performed per death. The method has been applied using data about COVID-19 from Italy. Results show a fatality ratio of about 0.9%, which is lower than previous findings. The number of actual infected people in Italy is also estimated, and results show that (i) infection started at the end of January 2020; (ii) a maximum number of about 100,000 new cases in one day was reached at the beginning of March 2020; (iii) the estimated cumulative number of infections at the beginning of October 2020 is about 4.2 million cases in Italy (more than 120 million worldwide, if a generalization is conjectured as reasonable). Therefore, the prevalence at the beginning of October 2020 is estimated at about 6.9% in Italy (1.6% worldwide, if a generalization is conjectured)
Case fatality rate · Coronavirus disease 2019 (COVID-19 · Disease · Environmental health · Estimation · Generalization · Infectious disease (medical specialty · Pandemic · Pathology · Population · Public health · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 · COVID-19 Clinical Research Studies · COVID-19 epidemiological studies · Demography · Mathematics · Medicine · SARS-CoV-2 and COVID-19 Research · Epidemiology · Internal Medicine
The Incubation Period of Coronavirus Disease 2019 (Covid-19) From Publicly Reported Confirmed Cases
Hospitalization and Mortality among Black Patients and White Patients with Covid-19
A novel coronavirus outbreak of global health concern
Coronavirus Infections—More Than Just the Common Cold
Coronavirus disease 2019 (Covid-19)
Presumed Asymptomatic Carrier Transmission of Covid-19
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
First Case of 2019 Novel Coronavirus in the United States
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Clinical course and risk factors for mortality of adult inpatients with Covid-19 in Wuhan, China
| Highly cited | No |
|---|